FDA OKs Powerful New Opioid Despite Criticisms

An FDA advisory committee did recommend for approval of Dsuvia in a 10-3 vote last month.  But the committee's chair took the highly unusual move of voicing his opposition at that time. Dr. Raeford Brown, a professor of anesthesiology and pediatrics at the University of Kentucky, urged the FDA to reject the drug.

from WebMD Health https://ift.tt/2yUPUJ1